期刊
EXPERT REVIEW OF MEDICAL DEVICES
卷 15, 期 5, 页码 323-336出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17434440.2018.1462697
关键词
Bioartificial kidney; wearable artificial kidney; protein bound uremic toxins; implantable artificial kidney; renal replacement therapy
资金
- Dutch Kidney Foundation
- European Commission (WEAKID, Horizon research and innovation program) [733169]
- RegMed XB (REGenerative MEDicine crossing Borders)
- University of Twente
- University of Utrecht
- University Medical Center Utrecht
Introduction: Since the advent of peritoneal dialysis (PD) in the 1970s, the principles of dialysis have changed little. In the coming decades, several major breakthroughs are expected.Areas covered: Novel wearable and portable dialysis devices for both hemodialysis (HD) and PD are expected first. The HD devices could facilitate more frequent and longer dialysis outside of the hospital, while improving patient's mobility and autonomy. The PD devices could enhance blood purification and increase technique survival of PD. Further away from clinical application is the bioartificial kidney, containing renal cells. Initially, the bioartificial kidney could be applied for extracorporeal treatment, to partly replace renal tubular endocrine, metabolic, immunoregulatory and secretory functions. Subsequently, intracorporeal treatment may become possible.Expert commentary: Key factors for successful implementation of miniature dialysis devices are patient attitudes and cost-effectiveness. A well-functioning and safe extracorporeal blood circuit is required for HD. For PD, a double lumen PD catheter would optimize performance. Future research should focus on further miniaturization of the urea removal strategy. For the bio-artificial kidney (BAK), cost effectiveness should be determined and a general set of functional requirements should be defined for future studies. For intracorporeal application, water reabsorption will become a major challenge.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据